Lack of correlation between IgG T-lymphocyte flow cytometric crossmatches with primary renal allograft outcome.
The flow cytometric crossmatch (FCXM) has been reported to be more sensitive and capable of detecting very low levels of antibodies than the normally used complement dependent cytotoxicity test. We studied both the two colour IgG T cell FCXM and CDC-XM in 146 renal allograft recipients, 111 primary and 35 regrafts, of which 26% (29/111) of 1st and 20% (7/35) of regrafts had a positive FCXM. There was no overall correlation between the FCXM results and early graft outcome in primary renal allografts. The FCXM did not appear to have any advantage over the CDC-XM in predicting graft outcome in unsensitized first grafts. In the small number of regrafts studied, a positive FCXM was associated with a higher degree of graft failure. FCXM can exhibit false negative results if sera are used solely neat although these prozone phenomena do not influence subsequent graft outcome.
Evans
P R
PR
Wessex Immunology Service, Southampton University Hospitals, Tenovus Research Laboratories, Tremona Rd., Southampton, Hampshire, S09 4XY, United Kingdom.
Lane
A C
AC
Lambert
C M
CM
Reynolds
W M
WM
Wilson
P J
PJ
Harris
K R
KR
Slapak
M
M
Lee
H A
HA
Smith
J L
JL
D000328:Adult; D000368:Aged; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006085:Graft Survival / Q000276:immunology; D006650:Histocompatibility Testing / Q000379:methods; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D007518:Isoantibodies / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012086:Reoperation; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007074:Immunoglobulin G; D007518:Isoantibodies